Latest issueWest Valley hosts a state playoff game; US 395 lanes close near FreyaRead now

← Spokane Valley news

HealthSaturday, November 7

Providence tightens visitor rules at Spokane and Stevens county hospitals amid respiratory illnesses

The Daily Spokane Valley teamFrom Saturday’s edition · 1 min read · 2 sources

ShareEmailFacebookX

If you're visiting someone at a Providence hospital, check the rules first. KHQ reports the hospitals put visitor restrictions in place Friday because of increased respiratory illnesses, while KXLY says the tightened rules start Monday, Nov. 9 and cover Providence Medical Group clinics, too. Visiting hours are 8 a.m. to 8 p.m. at Sacred Heart Medical Center, Holy Family, Mount Carmel, St. Joseph's and St. Luke's Rehabilitation.

Visiting hours run 8 a.m. to 8 p.m. at five hospitals

Five Providence hospitals in Spokane and Stevens counties

Midnight6 a.m.Noon6 p.m.8 a.m.to 8 p.m.
  • 8 a.m. to 8 p.m.Visiting hours
No limits
Pediatric, NICU, labor and delivery

Sources: NonStop Local KHQ, KXLY.com

View as table
WhenWhat
8 a.m. to 8 p.m.Visiting hours
No limitsPediatric, NICU, labor and delivery

Visitors check in at a screening desk for a pass, and Providence highly encourages masks. Providence asks you to review its visitor policies before you come.

  • Inpatients not in isolation: two visitors at a time
  • Isolation patients: two visitors per day, in full protective gear
  • Emergency department: two visitors, or one at a time if isolated
  • Exceptions: clergy, end-of-life patients, some interpretation needs

Under 12Visitors this age are barred from Children's Hospital inpatient units

The ban also covers the Women's Health Center and includes siblings. Providence will re-evaluate it in the spring.

Source: KXLY.com

Sources: NonStop Local KHQ, KXLY.com

Read it in the full edition

More from Saturday’s edition

Read the edition
All health news
  1. The Spokesman-Review12 hours ago

    J&J Backs Psychedelic-Inspired Biotech in $100 Million Round, on The Spokesman-Review

    Johnson & Johnson is backing a biotech company developing psychedelic-inspired medicines that promise to treat depression without the hallucinations, leading a $100 million financing round as pharmaceutical companies increasingly embrace a once-fringe field. The investment in privately held Delix Therapeutics Inc., through J&J’s venture capital arm, was part of an oversubscribed funding round co-led by SV Health Investors’ Dementia Discovery Fund.